Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.
2.

Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.

Zhou L, He X, Gao B, Xiong S.

J Virol. 2015 Oct;89(20):10512-23. doi: 10.1128/JVI.01028-15. Epub 2015 Aug 12.

3.

Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice.

Gao G, Zhang J, Si X, Wong J, Cheung C, McManus B, Luo H.

Am J Physiol Heart Circ Physiol. 2008 Jul;295(1):H401-8. doi: 10.1152/ajpheart.00292.2008. Epub 2008 May 30.

4.

Effect of prophylactically applied CpG ODN on the development of myocarditis in mice infected with Coxsackievirus B3.

Zhao T, Wu X, Song D, Fang M, Guo S, Zhang P, Wang L, Wang L, Yu Y.

Int Immunopharmacol. 2012 Dec;14(4):665-73. doi: 10.1016/j.intimp.2012.09.018. Epub 2012 Oct 9.

PMID:
23063973
5.

Effect of verapamil on acute coxsackievirus B3 murine myocarditis.

Xu Y, Yang YZ, Chen HZ, Jin PY, Guo Q, Zhao WZ, Yang JH, Cai QX, Zhou YC.

Chin Med J (Engl). 1992 Oct;105(10):818-21.

PMID:
1337875
6.

A phosphorothioate antisense oligodeoxynucleotide specifically inhibits coxsackievirus B3 replication in cardiomyocytes and mouse hearts.

Yuan J, Cheung PK, Zhang H, Chau D, Yanagawa B, Cheung C, Luo H, Wang Y, Suarez A, McManus BM, Yang D.

Lab Invest. 2004 Jun;84(6):703-14.

7.

QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.

Song X, Liu Z, Wang H, Xin Y, Wang X, Chen J, Shi Y, Zhang C, Hui R.

Exp Biol Med (Maywood). 2007 Dec;232(11):1441-8.

PMID:
18040068
8.

Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury.

Dörner A, Grunert HP, Lindig V, Chandrasekharan K, Fechner H, Knowlton KU, Isik A, Pauschinger M, Zeichhardt H, Schultheiss HP.

J Mol Med (Berl). 2006 Oct;84(10):842-51. Epub 2006 Aug 5.

PMID:
16924471
9.

Direct interferon-gamma-mediated protection caused by a recombinant coxsackievirus B3.

Henke A, Zell R, Martin U, Stelzner A.

Virology. 2003 Oct 25;315(2):335-44.

10.

Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis.

Opavsky MA, Martino T, Rabinovitch M, Penninger J, Richardson C, Petric M, Trinidad C, Butcher L, Chan J, Liu PP.

J Clin Invest. 2002 Jun;109(12):1561-9.

11.

Protective effects of 20(s)-protopanaxtriol on viral myocarditis infected by coxsackievirus B3.

Wang X, Wang Y, Ren Z, Qian C, Li Y, Wang Q, Zhang Y, Zheng L, Jiang J, Yang C, Wang D, Zhang Y, Fan J, Wang Y.

Pathobiology. 2012;79(6):285-9. doi: 10.1159/000331229. Epub 2012 Jun 9.

PMID:
22688124
12.

Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.

Stein EA, Pinkert S, Becher PM, Geisler A, Zeichhardt H, Klopfleisch R, Poller W, Tschöpe C, Lassner D, Fechner H, Kurreck J.

J Infect Dis. 2015 Feb 15;211(4):613-22. doi: 10.1093/infdis/jiu504. Epub 2014 Sep 5.

13.

Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis.

Weithauser A, Bobbert P, Antoniak S, Böhm A, Rauch BH, Klingel K, Savvatis K, Kroemer HK, Tschope C, Stroux A, Zeichhardt H, Poller W, Mackman N, Schultheiss HP, Rauch U.

J Am Coll Cardiol. 2013 Nov 5;62(19):1737-45. doi: 10.1016/j.jacc.2013.05.076. Epub 2013 Jul 17.

14.

Nitric oxide and murine coxsackievirus B3 myocarditis: aggravation of myocarditis by inhibition of nitric oxide synthase.

Hiraoka Y, Kishimoto C, Takada H, Nakamura M, Kurokawa M, Ochiai H, Shiraki K.

J Am Coll Cardiol. 1996 Nov 15;28(6):1610-5.

15.

Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice.

Zell R, Markgraf R, Schmidtke M, Görlach M, Stelzner A, Henke A, Sigusch HH, Glück B.

Med Microbiol Immunol. 2004 May;193(2-3):91-100. Epub 2003 Sep 26.

PMID:
14513374
16.

Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in mice.

Padalko E, Verbeken E, Matthys P, Aerts JL, De Clercq E, Neyts J.

BMC Microbiol. 2003 Dec 21;3:25.

17.

Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice.

Yanagawa B, Spiller OB, Proctor DG, Choy J, Luo H, Zhang HM, Suarez A, Yang D, McManus BM.

J Infect Dis. 2004 Apr 15;189(8):1431-9. Epub 2004 Apr 5.

18.

Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis.

Wang YF, Wang XY, Ren Z, Qian CW, Li YC, Kaio K, Wang QD, Zhang Y, Zheng LY, Jiang JH, Yang CR, Liu Q, Zhang YJ, Wang YF.

Antiviral Res. 2009 Nov;84(2):150-8. doi: 10.1016/j.antiviral.2009.08.004. Epub 2009 Aug 20.

PMID:
19699238
19.

Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.

Yun SH, Lee WG, Kim YC, Ju ES, Lim BK, Choi JO, Kim DK, Jeon ES.

J Infect Dis. 2012 Feb 1;205(3):491-7. doi: 10.1093/infdis/jir745. Epub 2011 Dec 29.

20.

Blockade of interleukin-17A protects against coxsackievirus B3-induced myocarditis by increasing COX-2/PGE2 production in the heart.

Xie Y, Chen R, Zhang X, Yu Y, Yang Y, Zou Y, Ge J, Chen H, Garzino-Demo A.

FEMS Immunol Med Microbiol. 2012 Apr;64(3):343-51. doi: 10.1111/j.1574-695X.2011.00918.x. Epub 2011 Dec 22.

Items per page

Supplemental Content

Write to the Help Desk